OnTrk—The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology
- 30 September 2009
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 15 (19), 5962-5967
- https://doi.org/10.1158/1078-0432.ccr-08-0651
Abstract
In the beginning, Trk was an oncogene. Yet Neurotrophin-Trk signaling came to preeminence in the field of neurobiology. Now it is appreciated that Trks regulate important processes in nonneuronal cells and, in addition to their impact on tumors of neural origin, may contribute to the pathogenesis of carcinomas, myelomas, and prostate and lymphoid tumors. Although mutations and rearrangements of Trk are seen only sporadically in human cancers, such as medullary thyroid carcinoma, a number of recent studies indicate that expression of TrkB contributes to tumor pathology. In neuroblastoma, TrkA expression marks good prognosis which TrkB and Brain-derived neurotrophic factor (BDNF) expression marks poor prognosis. Activation of the BDNF/TrkB signal transduction pathway also stimulates tumor cell survival and angiogenesis and contributes to resistance to cytotoxic drugs and anoikis, enabling cells to acquire many of the characteristic features required for tumorigenesis. Small molecule inhibitors, such as Cephalon's CEP-701, are in phase 1 and 2 clinical trials, and a series of AstraZeneca Trk inhibitors are poised to enter the clinic. As monotherapy, inhibitors may be effective only in tumors with activating Trk mutations. Important clinical follow-up will be the assessment of Trk inhibitors in combination with standard chemo- or radiotherapy or other signal transduction pathway inhibitors. (Clin Cancer Res 2009;15(19):5962–7)Keywords
This publication has 78 references indexed in Scilit:
- Emerging roles for centromeres in meiosis I chromosome segregationNature Reviews Genetics, 2008
- Requirement of 3-Phosphoinositide-Dependent Protein Kinase-1 for BDNF-Mediated Neuronal SurvivalJournal of Neuroscience, 2008
- Dieldrin promotes resistance to anoikis in breast cancer cells in vitroReproductive Toxicology, 2008
- Zinc-Mediated Transactivation of TrkB Potentiates the Hippocampal Mossy Fiber-CA3 Pyramid SynapseNeuron, 2008
- BDNF: A key regulator for protein synthesis-dependent LTP and long-term memory?Neurobiology of Learning and Memory, 2007
- Oncogenic rearrangements of the NTRK1/NGF receptorCancer Letters, 2006
- Genetic and Pharmacologic Identification of Akt as a Mediator of Brain-Derived Neurotrophic Factor/TrkB Rescue of Neuroblastoma Cells from Chemotherapy-Induced Cell DeathCancer Research, 2005
- Analysis of the Human TrkB Gene Genomic Organization Reveals Novel TrkB Isoforms, Unusual Gene Length, and Splicing MechanismBiochemical and Biophysical Research Communications, 2002
- Up-Regulation of Insulin-Like Growth Factor-II Expression Is a Feature of TrkA but Not TrkB Activation in SH-SY5Y Neuroblastoma CellsThe American Journal of Pathology, 1999
- Expression of neurotrophins and their receptors in the mammalian ovary is developmentally regulated: changes at the time of folliculogenesisEndocrinology, 1995